/Companies

Navigator Medicines

Scotch Plains, US · Founded 2024 · Delaware corporation · 2 known investors

Find your way into Navigator Medicines

Sign up to see every warm intro you have to Navigator Medicines

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Navigator Medicines team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Develops antibodies for treating autoimmune diseases.

Founders & leadership

NM
NAVEEN MANU DARYANIExecutive
TB
TAUSIF BUTTExecutive
SF
SCOTT FORRESTExecutive
KG
KRISTIE GREBEExecutive
SB
STEPHEN BASIL THOMASNamed on SEC filing
WD
WILLIAM DALEY BONIFICIONamed on SEC filing

Board

ALANDREW LEVIN
ANDREW LEVINBoard directorPartner at RA Capital
WJWOUTER JOUSTRA
WOUTER JOUSTRABoard directorGeneral Partner at Forbion
MV
MATHIAS VINTHERBoard director
KF
KHUREM FAROOQBoard director

Investors · 2

Reported raises · per SEC filings

Form D private placements

$60M disclosed across 2 rounds · 2024–2026

▶$10MraisedSep 2026 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • TAUSIF BUTTExecutive Officer, Director, Promoter
  • STEPHEN BASIL THOMASExecutive Officer, Director, Promoter
  • SCOTT FORRESTExecutive Officer
  • WOUTER JOUSTRADirector
  • KHUREM FAROOQDirector
  • MATHIAS VINTHERDirector
  • KRISTIE GREBEExecutive Officer
Offering amount
$40M
Amount sold
$10M
First sale
Sep 2026
Incorporated
Corporation, Delaware, 2024
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$50MraisedSep 2024 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • NAVEEN MANU DARYANIExecutive Officer
  • ANDREW LEVINDirector
  • STEPHEN BASIL THOMASExecutive Officer, Director, Promoter
  • WILLIAM DALEY BONIFICIOExecutive Officer, Promoter
  • WOUTER JOUSTRADirector
Offering amount
$100M
Amount sold
$50M
First sale
Aug 2024
Incorporated
Corporation, Delaware, 2024
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Navigator Medicines do?
Develops antibodies for treating autoimmune diseases.
Who are Navigator Medicines's investors?
Navigator Medicines's investors include RA Capital, Forbion.
How much funding has Navigator Medicines raised?
Navigator Medicines has disclosed $60M raised across 2 rounds.
Where is Navigator Medicines headquartered?
Navigator Medicines is headquartered in Scotch Plains, US.